Halfway through 2026, five themes have taken shape across the global healthcare landscape. In a year headlined by strong M&A activity, cross-border partnerships and geopolitical and regulatory uncertainty, the sector has shown resilience and robustness. Despite macro headwinds tied to global volatility, capital markets and M&A activity show no signs of slowing down. Areas like biopharma and biotech have seen strong activity, as companies make strategic acquisitions to replenish pipelines. Here’s a deeper dive into themes that are defining the year — and a peek at what’s ahead.
Read the full article: J.P.Morgan Healthcare Markets Outlook: A “Dynamic” Landscape Ripe for M&A Deals and Cross-Border Partnerships //
Source: https://www.jpmorgan.com/insights/banking/investment-banking/healthcare-mid-year-outlook